drugset / Trial / NCT00758303
A Study to Evaluate the Lipid Regulating Effects of TRIA-662
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine the effectiveness and safety of TRIA-662 (also known as 1-MNA) in treating elevated triglyceride levels in patients not receiving lipid lowering treatment. This study will determine the effects of TRIA-662 on commonly measured blood fats that are known to be important in the prevention of vascular disease.
Timeline
- Start
- 2007-09
- Primary completion
- 2008-12
- Completion
- 2008-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | TRIGONELLAMIDE | Small molecule | 30 mg | — |
| Comparator | TRIGONELLAMIDE | Small molecule | 90 mg | — |